Company intelligence / Profile preview

Evince Biosciences

Carlsbad, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Evince Biosciences was a private U.S. biotechnology company focused on AI-enabled drug discovery and lead optimization. The company developed the AVO (Autonomous Virtual Organism) platform, which combined biological simulation, machine learning, and ADMET-informed screening to identify small-molecule leads and novel targets. Public descriptions indicate the company also had an internal cancer immunotherapy program, but no named clinical assets or human trials were identified. Available business-directory and market-intelligence sources indicate the company was founded in 2016 in Carlsbad, California and later became inactive/"deadpooled."

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Evince Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evince Biosciences.

Explore the full profile